1.
Long-term safety, tolerability, and efficacy of vismodegib in two patients with metastatic basal cell carcinoma and basal cell nevus syndrome. Dermatol Reports [Internet]. 2011 Dec. 1 [cited 2025 Jun. 18];3(3):e55. Available from: https://journals.pagepress.org/dr/article/view/dr.2011.e55